Suchergebnisse - "Frelikh, Galina A"

PubPharm (6)

1

Dose proportionality and bioavailability of quinoxaline-based JNK inhibitor after single oral and intravenous administration in rats

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2024

von Frelikh, G. | Yanovskaya, E. | Lakeev, A. | +3

2

Novel aspects of taxifolin pharmacokinetics : Dose proportionality, cumulative effect, metabolism, microemulsion dosage forms

enthalten in: Journal of pharmaceutical and biomedical analysis | 2023

von Lakeev, A. | Yanovskaya, E. | Yanovsky, V. | +2

3

Corrigendum to "LC-MS/MS method for the determination of a semi-synthetic phenolic antioxidant 2,6-diisobornyl-4-methylphenol in rats after different administration routes" [J. Chromatogr. B 1213 (2022) 123537

enthalten in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 2023

von Lakeev, A. | Yanovskaya, E. | Yanovsky, V. | +4

ErratumFor: J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Dec 15;1213:123537. - PMID 36455390

4

Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS

enthalten in: Bioanalysis | 2023

von Lakeev, A. | Frelikh, G. | Yanovskaya, E. | +2

5

LC-MS/MS method for the determination of a semi-synthetic phenolic antioxidant 2,6-diisobornyl-4-methylphenol in rats after different administration routes

enthalten in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 2022

von Lakeev, A. | Yanovskaya, E. | Yanovsky, V. | +4

ErratumIn: J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Jan 15;1215:123581. - PMID 36586342

6

Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC-MS/MS

enthalten in: Bioanalysis | 2022

von Lakeev, A. | Frelikh, G. | Yanovskaya, E. | +2

1
[1]